Özlem Selçuk1, Vildan Yayla2, Murat Çabalar2, Vildan Güzel3, Samiye Uysal2, Asuman Gedikbaşi4. 1. Bulanık State Hospital, Neurology Clinics, Muş, Turkey. 2. Bakırköy Dr. Sadi Konuk Education and Research Hospital, Neurology Clinics, İstanbul, Turkey. 3. Van Region Training and Research Hospital, Neurology Clinics, Van, Turkey. 4. Bakırköy Dr. Sadi Konuk Education and Research Hospital, Biochemistry Clinics, İstanbul, Turkey.
Abstract
INTRODUCTION: S100B protein, which helps nerve development and differentiation, is produced by astrocytes and can be detected in peripheral circulation after brain damage. In this study, we aimed to investigate the relationship between the serum S100B protein level and the infarction volume and clinical outcome and also the early prognostic role of serum S100B protein in patients with ischemic stroke. METHOD: Fifty patients admitted in the first 24-hour period of acute ischemic stroke were evaluated prospectively, and the findings were compared to those of the controls (n=26). S100B levels of the patients and neurological findings on days 1, 3, and 5 and their functional outcomes on the discharge day and at the first month were recorded by the same examiner. RESULTS: S100B levels were not affected by sex, age, or concomitant systemic diseases. The maximum levels of S100B were recorded on the 3rd day, and there was a correlation between infarct size and S100B levels. No correlation between the severity of stroke and S100B level was found. There was a poor correlation between the functional outcomes of the patients at the 1st month and S100B levels and on the 3rd day. CONCLUSION: The detection of high S100B levels in peripheral circulation after acute ischemic stroke and the correlations of S100B levels with infarct size (good) and disability (poor) imply that S100B protein may be used as a peripheral marker in acute ischemic stroke patients.
INTRODUCTION:S100B protein, which helps nerve development and differentiation, is produced by astrocytes and can be detected in peripheral circulation after brain damage. In this study, we aimed to investigate the relationship between the serum S100B protein level and the infarction volume and clinical outcome and also the early prognostic role of serum S100B protein in patients with ischemic stroke. METHOD: Fifty patients admitted in the first 24-hour period of acute ischemic stroke were evaluated prospectively, and the findings were compared to those of the controls (n=26). S100B levels of the patients and neurological findings on days 1, 3, and 5 and their functional outcomes on the discharge day and at the first month were recorded by the same examiner. RESULTS:S100B levels were not affected by sex, age, or concomitant systemic diseases. The maximum levels of S100B were recorded on the 3rd day, and there was a correlation between infarct size and S100B levels. No correlation between the severity of stroke and S100B level was found. There was a poor correlation between the functional outcomes of the patients at the 1st month and S100B levels and on the 3rd day. CONCLUSION: The detection of high S100B levels in peripheral circulation after acute ischemic stroke and the correlations of S100B levels with infarct size (good) and disability (poor) imply that S100B protein may be used as a peripheral marker in acute ischemic strokepatients.
Authors: Christian Foerch; Oliver C Singer; Tobias Neumann-Haefelin; Richard du Mesnil de Rochemont; Helmuth Steinmetz; Matthias Sitzer Journal: Arch Neurol Date: 2005-07
Authors: T Bertsch; W Casarin; M Kretschmar; W Zimmer; S Walter; C Sommer; F Muehlhauser; A Ragoschke; S Kuehl; R Schmidt; B P Eden; C Nassabi; T Nichterlein; K Fassbender Journal: Clin Chem Lab Med Date: 2001-04 Impact factor: 3.694
Authors: K Fassbender; R Schmidt; A Schreiner; M Fatar; F Mühlhauser; M Daffertshofer; M Hennerici Journal: J Neurol Sci Date: 1997-05-01 Impact factor: 3.181
Authors: Raf Brouns; Bart De Vil; Patrick Cras; Didier De Surgeloose; Peter Mariën; Peter P De Deyn Journal: Clin Chem Date: 2009-12-03 Impact factor: 8.327
Authors: Christopher Beer; David Blacker; Michael Bynevelt; Graeme J Hankey; Ian B Puddey Journal: J Neuroinflammation Date: 2010-10-29 Impact factor: 8.322
Authors: Yun-Ju Lai; Sandra K Hanneman; Rebecca L Casarez; Jing Wang; Louise D McCullough Journal: Am J Transl Res Date: 2019-08-15 Impact factor: 4.060